JP6956569B2 - Residual drug management device and residual drug management system - Google Patents

Description

The present invention relates to a residual drug management device and a residual drug management system, and is particularly suitable for use in a system for managing residual drug left over by a patient.

Medicines are one of the medicines that are indispensable for the treatment of illnesses and injuries, but "residual medicines", in which a large amount of medicines are left over due to forgetting to take or leftovers, have become a major social problem. It is said that the potential annual drug costs such as missed doses are estimated to be about 50 billion yen or 60 billion yen. The causes of residual medicine are that there are many medicines to be used in combination, so I can't take it because I can't organize it, I don't take it because I don't have the knowledge of medicine, I don't take it because I'm afraid of side effects, and I have to adjust it myself because I'm not sick. There are various things such as not drinking. In particular, elderly people are said to have many prescription drugs and many leftovers.

Against this background, in recent years, various measures for utilizing and reducing residual medicine have been examined and implemented in order to reduce medical expenses in the country, but no effective solution has been found. Fundamentally, checking the medicines left in the patient's hands is an effective way to reduce medical costs.

In response to this, pharmacists have begun managing residual medicine in 2012. Specifically, the number of medicines that should be prescribed minus the number of surplus medicines is given to the patient. That is, when a pharmacy that accepts a prescription for a patient confirms that the patient has residual medicine, he / she consults with a doctor and takes measures such as dispensing after receiving an instruction to change the prescription. In addition, the revised ministerial ordinance that came into effect on April 1, 2014 allows pharmacists to reduce the amount of dispensing by themselves, subject to the consent of the prescribing doctor.

However, it is difficult for pharmacists to check the remaining drug status of patients, and the current situation is that the above-mentioned adjustment of residual drug does not lead to the expected reduction in medical expenses. It is also necessary to reduce the residual drug by recommending medication when the patient is not taking the drug that should be taken continuously. However, a pharmacist who only comes into contact with the patient when the prescription is given usually does not know the patient's usual medication status, and it is difficult for the pharmacist to properly manage the medication.

In addition, Patent Document 1 discloses a system for supporting medication management by a pharmacy. Further, Patent Document 2 discloses a system for supporting medication management by the patient at home, the patient's family, a caregiver, or the like.

In the care support system described in Patent Document 1, the pharmacy client terminal device outputs the receipt information created based on the prescription information created by the doctor, and the medication schedule created based on the prescription information is stored in the data center. Output to. On the other hand, the long-term care visit client terminal device outputs the medication instruction report information including the medication record indicating whether the patient is taking the medication according to the medication schedule to the data center. The data center has a storage unit for storing prescription information, medical receipt information, schedule information, and medication instruction report information, and shares the information.

In the system described in Patent Document 2, the medication time information indicating the time to be taken for each drug, the dosage information indicating the dose per dose, and the medication-related data related to the dose information indicating the total dose are input, and the medication-related data is input. A photograph of the appearance of each medicine is stored in association with the medicine, and information such as the time to take the medicine and the appearance of the medicine to be taken is displayed and notified. In addition, if a specific operation indicating that the patient has taken the drug has not been input for a predetermined number of times even after a certain period of time has passed from the time when the drug should be taken, or if the remaining amount of the drug falls below the predetermined value, the predetermined report destination Prevent forgetting to take the medicine or running out of medicine by notifying the person who is subject to medication management of any abnormalities or the status of remaining medication.

Japanese Unexamined Patent Publication No. 2012-174066 Japanese Unexamined Patent Publication No. 2014-194716

However, in the prior art described in Patent Document 1, it is possible to grasp the remaining drug status of the patient by sharing the prescription information, the receipt information, the schedule information and the medication instruction report information, but the remaining drug can be obtained. There is no mechanism to reduce or encourage patients to take medication. Therefore, the patient's residual drug cannot be effectively reduced.

Further, in the prior art described in Patent Document 2, since there is a mechanism for encouraging the patient to take the medicine, it is possible to prevent forgetting to take the medicine. However, the prior art described in Patent Document 2 does not provide a mechanism for managing residual drug when there is a drug left untreated by the patient's will. Therefore, even if the technique described in Patent Document 2 can reduce the residual drug of a patient to some extent, it cannot be said to be sufficient.

The present invention has been made to solve such a problem, and an object of the present invention is to enable an effective reduction of a patient's residual drug.

In order to solve the above-mentioned problems, the present invention provides medication record information including whether or not the patient actually took the medication according to the medication schedule created based on the prescription information of the drug, and the reason why the patient did not take the drug. Based on the reasons for taking and not taking the medicine, I am trying to give either a notification for medication guidance or a notification for adjusting the next prescription amount.

According to the present invention configured as described above, it is possible to surely grasp the remaining medication status of the patient by acquiring the medication record information as to whether or not the patient actually took the medication according to the medication schedule. Then, if the patient does not take the medicine, a notification will be given for medication guidance if the patient does not take the medicine that should be taken continuously based on the medicine and the reason for not taking the medicine. Therefore, it is possible to reduce the residual drug by recommending the patient to take the drug. In addition, if the situation corresponds to a situation where temporary suspension of medication is permitted, a notification for adjusting the next prescription amount will be given, so reduce the next prescription amount by the amount of the remaining medicine grasped by the notification. It is possible to reduce the patient's residual medicine. As described above, according to the present invention, the residual drug of the patient can be effectively reduced.

It is a figure which shows the whole structure example of the residual medicine management system by this embodiment. It is a figure which shows an example of the care management screen provided to the caregiver terminal by the performance record management device of this embodiment. It is a figure which shows an example of the medication status input screen provided to the caregiver terminal by the performance record management device of this embodiment. It is a block diagram which shows the functional structure example of the residual medicine management apparatus by this Embodiment. It is a figure which organizes and shows the determination example by the notification determination part of this embodiment. It is a figure which shows the input example of the reason why a patient did not take a medicine.

Hereinafter, an embodiment of the present invention will be described with reference to the drawings. FIG. 1 is a diagram showing an overall configuration example of a residual drug management system according to the present embodiment. As shown in FIG. 1, the residual drug management system of the present embodiment includes a pharmaceutical institution terminal 100 that creates medication schedule information based on drug prescription information, a caregiver terminal 200 that inputs patient medication record information, and a caregiver terminal 200. It is configured to include a performance record management device 300 that manages patient medication record information and a residual drug management device 400 that manages the patient's residual drug.

The caregiver terminal 200 and the performance record management device 300 are connected via a communication network such as the Internet or a mobile phone network. The performance record management device 300 and the residual drug management device 400 are connected via a communication network such as the Internet, LAN, or WAN. The residual drug management device 400 and the pharmaceutical institution terminal 100 are connected via a communication network such as the Internet or a mobile phone network. The connection relationship shown here is an example, and is not limited to this.

The pharmaceutical institution terminal 100 is a terminal used by a pharmacist in a dispensing pharmacy, and is composed of, for example, a personal computer or a tablet. The pharmaceutical institution terminal 100 creates the patient's medication schedule information based on the prescription information of the medicine issued by the doctor. The medication schedule information is information indicating which medication to take, when and how many tablets to take. If there is also a pharmacist in a medical institution that has a doctor who issues a prescription, the medical institution terminal 100 may be a terminal used by the pharmacist in the medical institution.

The medication schedule information is created, for example, by the pharmacist operating the pharmaceutical institution terminal 100 while referring to the prescription information. Alternatively, it is also possible for the pharmaceutical institution terminal 100 to automatically create medication schedule information based on the prescription information.

The caregiver terminal 200 is, for example, a terminal used by a care staff who cares for a patient (which is a patient for a medical institution and a care recipient for a care facility) in a care facility, for example. It consists of a personal computer, tablet or smartphone. The caregiver terminal 200 inputs information related to the care record of the patient through an operation on a predetermined information input screen by the care staff. For example, various biological information such as body temperature, pulse, blood pressure, respiration, and SPO2, lifestyle information such as meal intake status, urination / defecation status, and patient's medication record information are input.

Here, the patient's medication record information indicates which drug was taken, how many tablets, when, or was not taken, and is information indicating the reason for not taking the drug. The medication schedule information described above indicates which patients should take which medications, how many tablets, and when. In the present embodiment, the medication schedule information created by the pharmaceutical institution terminal 100 is transmitted to the performance record management device 300 via the residual drug management device 400 and stored, and the stored medication schedule information is transmitted from the caregiver terminal 200. It is configured to be viewable.

FIG. 2 is a diagram showing an example of a care management screen provided to the caregiver terminal 200 by the performance record management device 300. Further, FIG. 3 is a diagram showing an example of a medication status input screen provided to the caregiver terminal 200 by the performance record management device 300. The long-term care staff can confirm the medication schedule and input the medication record information through these long-term care management screens and the medication status input screens.

As shown in FIG. 2, on the care management screen, a biometric information management area 21 for inputting and displaying biometric information of a patient, a dietary management area 22 for inputting and displaying a dietary intake status which is one of lifestyle information, The excretion management area 23 for inputting and displaying the excretion status, which is one of the lifestyle information, and the medication schedule area 24 for displaying a part of the medication schedule information are included. The long-term care management screen shown in FIG. 2 is a screen for inputting information on the long-term care record for a specific day.

The biological information management area 21 is an area for inputting the patient's biological information (body temperature, pulse, blood pressure, respiration, and SPO2 values) measured by the care staff. The meal management area 22 is an area for inputting how much the patient has ingested a meal. In the example of FIG. 2, it is possible to input either complete / half-meal / non-meal for each of breakfast, lunch, snack, midnight snack, and pre-sleep meal. The excretion control area 23 is an area for inputting a time zone in which urination and defecation are performed.

The medication schedule area 24 is an area for displaying the timing of when to take the medication based on the medication schedule information. In the example of FIG. 2, the timing of taking any of pre-meal / inter-meal / post-meal is displayed for each of breakfast, lunch, snack, dinner, and pre-sleep meal. It should be noted that the fact that all of the pre-meal / inter-meal / post-meal is hidden means that it is not the timing of taking the drug. In the example of FIG. 2, it is shown that the dosing timing is between meals before breakfast and between meals before sleep.

When any of pre-meal / inter-meal / post-meal is displayed in the medication schedule area 24, the medication status input screen shown in FIG. 3 is displayed. On the medication status input screen shown in FIG. 3, a drug information display area 31 that displays detailed information about the drug to be taken at the timing of the tapped area and a medication status input area for inputting the medication status by the patient of the drug are displayed. 32 and are included.

In the drug information display area 31, the name of the drug, the amount to be taken, and the image of the drug are displayed. This information is displayed based on the medication schedule information stored in the performance record management device 300. The drug information display area 31 can correctly grasp which drug should be taken when and in what amount when the care staff assists the patient in taking the drug according to the medication schedule, which is useful for preventing erroneous medication.

In the medication status input area 32, there are a medication button for inputting that the patient has taken the medication, a non-administration button for inputting that the patient has not taken the medication, and a reason button for inputting the reason for not taking the medication. include. When you tap the reason button, items that can be selected as the reason will pop up. The care staff selects and inputs the applicable reason from the pop-up items. In the present embodiment, it is possible to select any of abnormalities in the patient's biological information (hereinafter referred to as vital abnormalities), abnormalities in the patient's lifestyle (hereinafter referred to as lifestyle abnormalities), symptom improvement, and patient's self-intention. There is.

The care record information (including the medication record information) input from the caregiver terminal 200 through the biometric information management area 21, the diet control area 22, the excretion control area 23, and the medication status input area 32 of FIG. 3 is , It is transmitted from the caregiver terminal 200 to the performance record management device 300, and is sequentially stored in the performance record management device 300 as information on the care history. That is, the record management device 300 records and manages the medication record information input from the caregiver terminal 200.

The residual drug management device 400 acquires the medication record management device 300 from the medication record management device 300, and manages the patient's residual drug based on the medication record management device 300. Then, either a notification for medication instruction or a notification for adjusting the next prescription amount is given to the pharmaceutical institution terminal 100 (details of this will be described later).

The notification for medication guidance is information that informs the pharmacist of which drug of which patient was not taken and when, and gives advice on medication guidance. The pharmacist refers to the information on medication guidance notified to the pharmaceutical institution terminal 100 (hereinafter referred to as medication guidance information) and determines whether or not to take the medication immediately. Then, when it is determined that the drug should be taken immediately, information prompting the drug to be taken (hereinafter referred to as medication promotion information) is input from the pharmaceutical institution terminal 100 and transmitted to the residual drug management device 400. The residual drug management device 400 transmits and stores the medication promotion information received from the pharmaceutical institution terminal 100 to the performance record management device 300, and makes the stored medication promotion information viewable from the caregiver terminal 200. If the pharmacist determines that there is a high urgency to take the drug immediately, the care staff will be notified that the drug should be taken immediately using another means of communication such as e-mail or telephone.

The notification for adjusting the next prescription amount informs the pharmacist of which drug of which patient is not taken and how much is left over, and gives advice on adjusting the next prescription amount (hereinafter, next prescription adjustment). Information). When the pharmaceutical institution terminal 100 receives a notification for adjusting the next prescription amount from the residual drug management device 400, the next prescription adjustment information is stored in the pharmaceutical institution terminal 100 and issued by the doctor at least until the next prescription. When creating the medication schedule information based on the next prescription information given, the next prescription adjustment information is displayed as caution information. The pharmacist adjusts the prescription amount of the drug by referring to this next prescription adjustment information. For example, when the prescription amount indicated by the prescription information issued by the doctor is n tablets and the remaining drug amount indicated by the next prescription adjustment information is x tablets, (nx) tablets may be prescribed.

FIG. 4 is a block diagram showing a functional configuration example of the residual drug management device 400 according to the present embodiment. As shown in FIG. 4, the residual drug management device 400 of the present embodiment has, as its functional configuration, a medication schedule acquisition unit 41, a medication record acquisition unit 42, a notification determination unit 43, a notification execution unit 44, and a medication schedule providing unit 45. Is configured with.

Each of the above functional blocks 41 to 45 can be configured by any of hardware, DSP (Digital Signal Processor), and software. For example, when configured by software, each of the above functional blocks 41 to 45 is actually configured to include a computer CPU, RAM, ROM, etc., and is a program stored in a recording medium such as RAM, ROM, hard disk, or semiconductor memory. Is realized by the operation of.

The medication schedule acquisition unit 41 acquires medication schedule information created based on the prescription information of the drug from the pharmaceutical institution terminal 100. Here, it is assumed that the medication schedule information is acquired from the pharmaceutical institution terminal 100, but the present invention is not limited to this. For example, the medication schedule information created by the pharmaceutical institution terminal 100 may be stored in an external database, and the residual medication management device 400 may acquire the medication schedule information from the external database.

The medication schedule providing unit 45 provides the medication schedule information acquired by the medication schedule acquisition unit 41 to the performance record management device 300. As described above, the performance record management device 300 generates the medication schedule area 24 of the long-term care management screen shown in FIG. 2 based on the medication schedule information, and also generates the medication information display area 31 of the medication status input screen shown in FIG. Is generated and provided to the caregiver terminal 200.

The care staff using the caregiver terminal 200 operates the medication status input area 32 to input the medication record information while referring to the information displayed in the medication schedule area 24 and the medication information display area 31. The caregiver terminal 200 transmits the input medication record information to the record management device 300, and the record management device 300 sequentially records the medication record information as a history.

The medication record acquisition unit 42 acquires the medication record management device 300 including whether or not the patient actually took the drug and the reason for not taking the drug based on the medication schedule.

The notification determination unit 43 determines whether to give a notification for medication guidance or a notification for adjusting the next prescription amount based on the reasons for not taking the medicine and not taking the medicine indicated by the medication record information. do. The notification execution unit 44 sends the notification determined by the notification determination unit 43 to the pharmaceutical institution terminal 100.

Here, a determination example by the notification determination unit 43 will be described. For example, if the drug not taken is a high-risk drug defined as having a large effect on the body due to discontinuation of the drug, the notification determination unit 43 may provide guidance on taking the drug regardless of the reason for not taking the drug. It is determined that the notification will be given. High-risk drugs are drugs that require special attention to side effects and accidents and require the involvement of specialists (pharmacists, doctors, etc.) for safety management, and which drugs are high-risk drugs are defined in advance. Then, it shall be registered in the residual drug management device 400. The residual drug management device 400 determines that if the drug that has not been taken, which is indicated by the medication record information, corresponds to a high-risk drug, it gives a notification for medication guidance.

In this case, it is preferable to include information indicating that the drug that the patient did not take is a high-risk drug in the notification for medication instruction. The pharmacist who received the notification for the medication instruction on the pharmaceutical institution terminal 100 and confirmed the medication instruction information on the screen of the pharmaceutical institution terminal 100 grasps that the drug that the patient did not take is a high-risk drug. As a result, the medication promotion information is input from the pharmaceutical institution terminal 100 and transmitted to the residual drug management device 400.

The medication promotion information transmitted to the residual drug management device 400 can be viewed on the caregiver terminal 200 via the performance record management device 300. It is arbitrary in what manner the browsing is possible. For example, it is possible to pop-up the medication promotion information on the long-term care management screen or the top menu screen (not shown) shown in FIG. In this way, it is possible to effectively alert the care staff that the patient should immediately take the medicine that he / she did not take. In addition to the pop-up display, an alarm sound may be sounded.

In addition, the notification determination unit 43 takes the medicine not taken due to a vital abnormal value caution drug defined as having to refrain from taking the medicine due to an abnormal value related to the patient's biological information, or due to an abnormality related to the patient's lifestyle. If it is one of the lifestyle abnormalities caution drugs defined as needing to refrain from taking the drug, and the reason for not taking the drug is either a patient's vital abnormality or lifestyle abnormality, it is for medication guidance. Is determined to be notified. Here, it is assumed that which drug is a vital abnormal value caution drug or a lifestyle abnormality caution drug is also defined in advance and registered in the residual drug management device 400.

In this case, it is preferable to include information indicating that the drug that the patient did not take is a vital outlier caution drug or a lifestyle abnormality caution drug in the notification for medication instruction in this case. The pharmacist who received the notification for the medication instruction on the pharmaceutical institution terminal 100 and confirmed the medication instruction information on the screen of the pharmaceutical institution terminal 100 grasps that the situation should refrain from taking the medication, and the pharmacist terminal 100 The medication promotion information is not input from the above and transmitted to the residual medication management device 400.

In addition, instead of the medication promotion information, medication stop information notifying that the patient should refrain from taking medication while a vital abnormality or lifestyle abnormality is occurring is input from the pharmaceutical institution terminal 100 and transmitted to the residual medication management device 400. You may do so. The medication stop information transmitted to the residual drug management device 400 can also be viewed on the caregiver terminal 200 via the performance record management device 300. It is arbitrary in what manner the browsing is possible. For example, when the medication status input screen shown in FIG. 3 is displayed, it is possible to display the medication stop information in the medication status input screen. This effectively warns the care staff that they should refrain from taking medication if they have vital or lifestyle abnormalities when assisting the patient in taking the medication according to the medication schedule. Can be aroused.

In addition, the notification determination unit 43 indicates that the drug not taken is either a vital abnormal value caution drug or a lifestyle abnormality caution drug, and the reason for not taking the drug is either the patient's self-will or symptom improvement. If is, it is determined that the next notification for adjusting the prescription amount will be given. Furthermore, if the drug not taken does not fall under any of the high-risk drug, vital abnormal value caution drug, and lifestyle abnormality caution drug, the notification determination unit 43 determines the next prescription amount regardless of the reason for not taking the drug. It is determined that a notification for adjustment is given.

FIG. 5 is a diagram in which determination examples of the notification determination unit 43 described above are organized and shown. It should be noted that the determination content shown here is only an example, and the present invention is not limited thereto.

For example, in the above embodiment, when the drug not taken is a high-risk drug, it is described as giving a notification for medication instruction regardless of the reason for not taking the drug. In this case, the content of the notification for medication instruction may be changed depending on the reason for not taking the medication. For example, if the reason for not taking the drug is a patient's vital abnormalities, an abnormal value related to the patient's biological information may be included in the notification. In addition, if the reason for not taking the drug is a lifestyle-related abnormality of the patient, the notification may include information on the lifestyle-related abnormality.

Similarly, if the drug not taken is either a vital signs caution drug or a lifestyle abnormality caution drug, and the reason for not taking the drug is either a patient's vital signs abnormality or lifestyle abnormality. In the notification for medication instruction, the notification may include abnormal values related to the patient's biological information or abnormal information related to lifestyle habits. In this way, it is possible to provide useful information for the pharmacist to decide whether or not the patient should immediately take the medicine that was not taken.

As described in detail above, in the residual drug management system of the present embodiment, the medication schedule information created by the pharmaceutical institution terminal 100 based on the prescription information of the drug issued by the doctor is cared for through the performance record management device 300. It is provided to the person terminal 200, and the medication record information including whether or not the patient actually took the medication according to the medication schedule information and the reason for not taking the medication is input from the caregiver terminal 200 to the record management device 300. Record. Then, the residual drug management device 400 acquires the medication record management device 300 from the performance record management device 300, and based on the reasons for the medication not taken and the medication not taken, the notification for the medication instruction or the adjustment of the next prescription amount. Any of the notifications is sent to the pharmaceutical institution terminal 100.

According to the residual drug management system of the present embodiment configured in this way, the residual drug management device 400 acquires from the record management device 300 the medication record management device 300 whether or not the patient actually took the drug according to the drug schedule. As a result, the residual drug status of the patient can be reliably grasped by the residual drug management device 400. Then, when the patient does not take the medicine, based on the medicine and the reason for not taking the medicine, either the notification for the medication instruction or the notification for the adjustment of the next prescription amount is appropriately sent to the pharmaceutical institution terminal 100. Can be done for.

That is, in the case where the patient is not taking the medicine that should be taken continuously, the notification for the medication instruction is given to the medical institution terminal 100. In response to this notification, by recommending the patient to take medication through the care staff based on the medication promotion information provided from the pharmaceutical institution terminal 100 to the caregiver terminal 200 through the residual drug management device 400 and the performance record management device 300. It is possible to reduce the patient's residual drug. In addition, if the situation corresponds to a situation where temporary suspension of medication is permitted, a notification will be given for the next adjustment of the prescription amount. In response to this notification, it is possible to reduce the patient's residual drug by reducing the next prescription amount by the amount of the residual drug grasped by the notification. As described above, according to the present embodiment, the residual drug of the patient can be effectively reduced from two aspects.

In the above embodiment, an example in which both the notification for medication instruction and the notification for adjusting the next prescription amount are given to the pharmaceutical institution terminal 100 has been described, but the present invention is not limited thereto. For example, the notification execution unit 44 gives a notification for medication instruction to the performance record management device 300 in place of or in addition to the pharmaceutical institution terminal 100, and the performance record management device 300 is provided by the residual drug management device 400. The caregiver terminal 200 may be notified of the notification for medication instruction.

For example, in response to a notification for medication instruction given from the residual drug management device 400 to the pharmaceutical institution terminal 100, the medication promotion information transmitted from the pharmaceutical institution terminal 100 to the residual drug management device 400 is stored and history information. Accumulate as. Then, machine learning is performed using this history information, and a case in which there is a high possibility that medication promotion information is transmitted from the pharmaceutical institution terminal 100 is learned. After that, the notification determination unit 43 corresponds to a case in which there is a high possibility that medication promotion information is transmitted based on the reasons for not taking the medicine and not taking the medicine indicated by the medication record management device 300. When it is determined that the case is determined, a notification for medication instruction is given to the performance record management device 300, and the notification is notified to the caregiver terminal 200. Alternatively, the medication promotion information may be pushed and transmitted from the performance record management device 300 to the caregiver terminal 200.

In this way, in the case where it is learned that there is a high possibility of transmitting the medication promotion information at the discretion of the pharmacist, the notification for medication instruction is not transmitted (or transmitted) to the pharmaceutical institution terminal 100. In addition, it becomes possible to automatically provide medication promotion information to the caregiver terminal 200 via the performance record management device 300. As a result, it is possible to improve the work efficiency of the pharmacist using the residual drug management system of the present embodiment.

Further, in the above embodiment, based on the information input to the biological information management area 21, the meal management area 22 and the excretion management area 23 of the long-term care management screen shown in FIG. 2, the medication on the medication status input screen shown in FIG. 3 is taken. In the situation input area 32, the care staff manually selected the reason for not taking the drug. On the other hand, the following may be used. That is, the biological information and lifestyle information input to each of the above areas 21 to 23 and the reason for not taking the drug input from the medication status input area 32 are accumulated as history information, and machine learning is performed using this history information. By doing so, learn the cases in which the reason for vital or lifestyle abnormalities is likely to be selected. After that, if it is determined that the reason for the vital abnormality or lifestyle abnormality is likely to be selected based on the biological information and lifestyle information input in each area 21 to 23, the drug is taken. The reason why it was not done is to automatically select vital or lifestyle abnormalities.

For patients admitted to long-term care facilities, it is often difficult to detect abnormal values in lifestyle such as taking medicine, various vital values, and diet, urination, and defecation due to various conditions. On the other hand, by performing machine learning and automatically detecting anomalies as described above, it becomes possible to input the reason for not taking the drug without human judgment by the care staff.

Further, in the above embodiment, an example in which one of four reasons for the patient not taking the drug is selected from vital abnormalities, lifestyle abnormalities, symptom improvement, and self-intention has been described, but the present invention is not limited thereto. .. For example, as shown in FIG. 6, a more detailed reason may be selected for the above four reasons. In addition, the care staff may be allowed to enter comments at will. It is preferable that the input information is included in the notification given from the residual drug management device 400 to the pharmaceutical institution terminal 100.

Further, in the above embodiment, the residual drug management is performed in a form in which the care record system including the caregiver terminal 200 and the performance record management device 300 and the drug management system using the pharmaceutical institution terminal 100 and the residual drug management device 400 are fused. Although examples of configuring the system have been described, the present invention is not limited thereto. For example, if it is a system that can manage medication record information, it may be used in combination with a system other than the long-term care recording system.

Further, in the above embodiment, an example in which the performance record management device 300 and the residual drug management device 400 are separate devices has been described, but the present invention is not limited thereto. For example, the residual drug management device 400 may have the function of the performance record management device 300 and may be configured as one device.

Further, in the above embodiment, an example in which the residual drug management device 400 acquires the medication schedule information created by the pharmaceutical institution terminal 100 based on the prescription information of the drug from the pharmaceutical institution terminal 100 has been described. Not limited to. For example, the medication schedule information may be created by the residual drug management device 400.

Further, in the above embodiment, there is an example in which either a notification for medication guidance or a notification for adjusting the next prescription amount is given based on the reasons for not taking the medicine and not taking the medicine indicated by the medication record information. As described above, the present invention is not limited to this. For example, in addition to the above two notifications, a notification of discontinuation of medication may be given. For example, if the drug not taken indicated by the medication record information does not fall under any of the high-risk drug, vital abnormal value caution drug, and lifestyle abnormality caution drug, and the reason for not taking the drug is improvement of symptoms. You may give a notice of discontinuation of medication.

In addition, the above embodiments are merely examples of embodiment of the present invention, and the technical scope of the present invention should not be construed in a limited manner. That is, the present invention can be implemented in various forms without departing from its gist or its main features.

41 Medication schedule acquisition department 42 Medication record acquisition department 43 Notification judgment unit 44 Notification execution unit 100 Pharmaceutical institution terminal 200 Caregiver terminal 300 Performance record management device 400 Residual medication management device

Claims (7)

The medication schedule acquisition department that acquires medication schedule information created based on drug prescription information,
Based on the above medication schedule, the medication record acquisition department, which acquires medication record information including whether or not the patient actually took the drug and the reason for not taking the drug,
With a notification determination unit that determines whether to give a notification for medication guidance or a notification for adjusting the next prescription amount based on the reasons for not taking the medicine and not taking the medicine indicated by the above-mentioned medication record information. ,
It is equipped with a notification execution unit that performs notifications determined by the above notification determination unit .
The notification determination unit determines that the drug not taken is due to a vital abnormal value caution drug defined as the need to refrain from taking the drug due to an abnormal value related to the biological information of the patient, or due to an abnormality related to the lifestyle of the patient. If it is one of the lifestyle abnormalities caution medications defined as the need to refrain from taking the drug, and the reason for not taking the drug is either an abnormality in the biometric information of the patient or an abnormality in the lifestyle. Is a residual drug management device, which is determined to give a notification for the above-mentioned medication instruction. The notification determination unit is determined by the vital abnormal value caution drug defined that the drug not taken is required to refrain from taking the drug due to the abnormal value related to the biological information of the patient, or due to an abnormality related to the lifestyle of the patient. If it is one of the lifestyle abnormalities caution drugs defined as the need to refrain from taking the drug, and the reason for not taking the drug is either the patient's self-intention or the improvement of symptoms, the next time The residual drug management device according to claim 1 , wherein it is determined that a notification for adjusting a prescription amount is given. The medication schedule acquisition department that acquires medication schedule information created based on drug prescription information,
Based on the above medication schedule, the medication record acquisition department, which acquires medication record information including whether or not the patient actually took the drug and the reason for not taking the drug,
With a notification determination unit that determines whether to give a notification for medication guidance or a notification for adjusting the next prescription amount based on the reasons for not taking the medicine and not taking the medicine indicated by the above-mentioned medication record information. ,
It is equipped with a notification execution unit that performs notifications determined by the above notification determination unit .
The notification judgment unit defines that the drug that was not taken is a high-risk drug that is defined as having a large effect on the body due to discontinuation of the drug, and that it is necessary to refrain from taking the drug due to an abnormal value related to the biological information of the patient. If you do not fall under any of the above-mentioned vital abnormal value caution medicine and the lifestyle abnormality caution medicine defined as the need to refrain from taking the medicine due to the above-mentioned patient's lifestyle abnormality, the reason for not taking the medicine is as follows. Instead, the residual drug management device is characterized in that it is determined that the notification for the adjustment of the next prescription amount is given. If the drug that was not taken is a high-risk drug that is defined as having a large effect on the body due to discontinuation of the drug, the notification determination unit will provide the above-mentioned medication guidance regardless of the reason for not taking the drug. The residual drug management device according to claim 1 or 2 , wherein it is determined that the notification is to be performed. A pharmaceutical institution terminal that creates medication schedule information based on drug prescription information,
A performance record management device that manages medication performance information, including whether or not the patient actually took the medication and the reason for not taking the medication.
Equipped with a residual drug management device that manages residual drug
The above residual drug management device
The medication schedule acquisition department that acquires the medication schedule information from the pharmaceutical institution terminal,
The medication record acquisition department that acquires the above-mentioned medication record information from the above-mentioned record management device,
With a notification determination unit that determines whether to give a notification for medication guidance or a notification for adjusting the next prescription amount based on the reasons for not taking the medicine and not taking the medicine indicated by the above-mentioned medication record information. ,
It is provided with a notification execution unit that sends a notification determined by the notification determination unit to the pharmaceutical institution terminal .
The notification determination unit determines that the drug not taken is due to a vital abnormal value caution drug defined as the need to refrain from taking the drug due to an abnormal value related to the biological information of the patient, or due to an abnormality related to the lifestyle of the patient. If it is one of the lifestyle abnormalities caution medications defined as the need to refrain from taking the drug, and the reason for not taking the drug is either an abnormality in the biometric information of the patient or an abnormality in the lifestyle. Is a residual drug management system characterized in that it is determined to give a notification for the above-mentioned medication instruction. A pharmaceutical institution terminal that creates medication schedule information based on drug prescription information,
A performance record management device that manages medication performance information, including whether or not the patient actually took the medication and the reason for not taking the medication.
Equipped with a residual drug management device that manages residual drug
The above residual drug management device
The medication schedule acquisition department that acquires the medication schedule information from the pharmaceutical institution terminal,
The medication record acquisition department that acquires the above-mentioned medication record information from the above-mentioned record management device,
With a notification determination unit that determines whether to give a notification for medication guidance or a notification for adjusting the next prescription amount based on the reasons for not taking the medicine and not taking the medicine indicated by the above-mentioned medication record information. ,
It is provided with a notification execution unit that sends a notification determined by the notification determination unit to the pharmaceutical institution terminal.
The notification judgment unit defines that the drug that was not taken is a high-risk drug that is defined as having a large effect on the body due to discontinuation of the drug, and that it is necessary to refrain from taking the drug due to an abnormal value related to the biological information of the patient. If you do not fall under any of the above-mentioned vital abnormal value caution medicine and the lifestyle abnormality caution medicine defined as the need to refrain from taking the medicine due to the above-mentioned patient's lifestyle abnormality, the reason for not taking the medicine is as follows. However, it is determined that the notification for the adjustment of the next prescription amount will be given.
A residual drug management system characterized by this. The performance record management device records and manages the medication record management information input from the caregiver terminal used by the care staff who cares for the patient.
The notification execution unit sends a notification for medication guidance to the performance record management device in place of or in addition to the pharmaceutical institution terminal.
The residual drug management system according to claim 5 or 6, wherein the performance record management device notifies the caregiver terminal of a notification for medication instruction.

Images